HAL vs VTGN · P/E 9.3, $19.05B cap vs rev $176.0K
Halliburton Company (HAL) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported VTGN revenue for 2023-03-31 was $176.0K. Net income was -$12.2M. VTGN currently screens at market cap $28.1M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the HAL and VTGN stock pages for the full models.
Not investment advice.